LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000435.2:c.3278G>T
NOTCH3
· NP_000426.2:p.(Cys1093Phe)
· NM_000435.2
GRCh37: chr19:15290932 C>A
·
GRCh38: chr19:15180121 C>A
Gene:
NOTCH3
Transcript:
NM_000435.2
Final call
Likely Pathogenic
PM1 moderate
PM2 supporting
PP2 supporting
PP3 strong
Variant details
Gene
NOTCH3
Transcript
NM_000435.2
Protein
NP_000426.2:p.(Cys1093Phe)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM1 (Moderate): p.(Cys1093Phe) alters a cysteine in the NOTCH3 EGF-like repeat hotspot where CADASIL-causing variants cluster.
2
PM2 (Supporting): the variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0.
3
PP2 (Supporting): missense, especially cysteine-altering, variants are the established NOTCH3/CADASIL disease mechanism.
4
PP3 (Strong): REVEL 0.962 exceeds the >=0.932 ClinGen SVI PP3_Strong threshold.
5
Overall: Likely Pathogenic - one Strong + one Moderate + two Supporting meet the generic ACMG/AMP 2015 Likely Pathogenic combination.
Final determination:
Generic ACMG/AMP 2015 fallback: PP3(strong) + PM1(moderate) + PM2(supporting) + PP2(supporting) satisfies the Likely Pathogenic combination (1 PS-level + 1 PM + 2 PP) and falls short of Pathogenic thresholds.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: p.(Cys1093Phe) is a missense change, so no null-variant mechanism (nonsense-mediated decay, truncation, or splice disruption) applies. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not assessed | Not assessed: ClinVar returned no prior pathogenic classification for any other nucleotide change producing the identical amino acid change, so no comparator exists. |
clinvar
|
| PS2 | Not assessed | Not assessed: no parental testing, maternity/paternity confirmation, or de novo observation was available for this variant. |
|
| PS3 | Not assessed | Not assessed: no functional assay data on this variant was available, and the literature search returned zero relevant studies. |
|
| PS4 | Not assessed | Not assessed: no affected-case counts, case-control enrichment, or clinical cohort evidence was available for this variant. |
|
| PM1 | Met | Met (Moderate): p.(Cys1093Phe) alters a cysteine within the NOTCH3 EGF-like repeat domain, a mutation-dense hotspot where CADASIL-causing cysteine variants cluster. |
pvs1_gene_context
|
| PM2 | Met | Met (Supporting): the variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, with no observed allele count or frequency. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| PM3 | Not assessed | Not assessed: no second pathogenic allele, phase result, or recessive-disease context was established for this variant. |
|
| PM4 | N/A | Not applicable: this missense change does not alter protein length, so the in-frame insertion/deletion and stop-loss criterion does not apply. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not assessed | Not assessed: no prior pathogenic missense change at codon 1093 was available as a comparator. |
pm5_candidates
clinvar
|
| PM6 | Not assessed | Not assessed: no unconfirmed de novo observation or parental testing was provided. |
|
| PP1 | Not assessed | Not assessed: no affected relatives, informative meioses, or segregation results were provided. |
|
| PP2 | Met | Met (Supporting): missense variants - especially cysteine-altering changes in the EGF-like repeats - are the established NOTCH3/CADASIL disease mechanism. |
pvs1_gene_context
|
| PP3 | Met | Met (Strong): REVEL score 0.962 exceeds the >=0.932 ClinGen SVI PP3_Strong calibration threshold. |
revel
|
| PP4 | Not assessed | Not assessed: no patient phenotype or diagnostic features were provided to establish a highly specific presentation. |
|
| PP5 | Not met | Not met: the exact variant is absent from ClinVar, with no expert-panel Pathogenic or Likely Pathogenic assertion. |
clinvar
|
| BA1 | Not met | Not met: the variant is absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, so no allele frequency reaches the stand-alone benign threshold. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS1 | Not met | Not met: no population allele frequency was observed in gnomAD, so the frequency is not higher than expected for the disease. |
gnomad_v2
gnomad_v4
gnomad_canada
|
| BS2 | Not assessed | Not assessed: no unaffected adult homozygotes or hemizygotes carrying the variant were reported. |
|
| BS3 | Not assessed | Not assessed: no functional assay evidence of normal (wild-type-like) protein function was available for this variant. |
|
| BS4 | Not assessed | Not assessed: no unaffected relatives tested or informative non-segregation data were provided. |
|
| BP1 | Not met | Not met: missense variation is the established NOTCH3 disease mechanism, so the truncation-predominant premise of BP1 does not apply. |
pvs1_gene_context
|
| BP2 | Not assessed | Not assessed: no phase, co-occurring pathogenic variant, or segregation data was available to evaluate the criterion. |
|
| BP3 | N/A | Not applicable: this missense change does not alter protein length within a repetitive region. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: REVEL 0.962 strongly supports pathogenicity and no splice disruption is predicted, so no benign-leaning computational signal exists. |
revel
spliceai
|
| BP5 | Not assessed | Not assessed: no alternative molecular explanation for the phenotype was identified. |
|
| BP6 | Not met | Not met: the exact variant is absent from ClinVar, with no expert-panel Benign or Likely Benign assertion. |
clinvar
|
| BP7 | N/A | Not applicable: this missense change alters the encoded protein sequence, so the silent-variant premise of BP7 does not hold. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.